Menu
Back to Journals » Drug Design, Development and Therapy » Volume 11
Original Research
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines
| Total article views | Abstract views | HTML views | PDF downloads | Totals | |
|---|---|---|---|---|---|
| 8,833 | Dovepress* | 7,340 | 803+ | 1,299 | 8,143 |
| PubMed Central* | 0 | 690 | 272 | 690 | |
| Totals | 7,340 | 1,493 | 1,571 | 8,833 | |
|
*Since 3 April 2017 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 6 | 1 | 0 | 0 | 2 | 3 |
View citations on PubMed Central and Google Scholar